Form 4: Medtronic Executive Michael Marinaro Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Michael Marinaro, EVP & President, Surgical OU at Medtronic plc, reported disposing of 575 ordinary shares to cover tax obligations arising from vesting restricted stock units.
Summary
- On March 3, 2025, Michael Marinaro, an Executive Vice President & President, Surgical OU at Medtronic plc, disposed of 575 ordinary shares.
- The transaction was executed to cover tax obligations related to the vesting of restricted stock units.
- The shares were disposed of at a price of $94.3.
- Following the transaction, Marinaro directly owns 40,675 ordinary shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to a routine transaction for tax purposes.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like executives and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors to gauge management's sentiment and confidence in the company's performance.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disposal of shares for tax purposes and does not indicate a change in the executive's long-term outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of share disposal transaction |
| 03/05/2025 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.